New Delhi, Aug 21 (IANS) South Korean company Samsung on Wednesday announced the rollout of irregular heart rhythm notification (IHRN) feature on its health monitor app for Galaxy watches in India.
According to the company, the new feature, combined with the app’s existing blood pressure and electrocardiogram (ECG) monitoring capabilities, helps detect heart rhythms suggestive of atrial fibrillation (AFib), offering Galaxy watch users a more comprehensive understanding of their heart health.
Once activated, the feature continuously checks for irregular heart rhythms in the background using the ‘BioActive Sensor’. If a certain number of consecutive measurements are irregular, the smartwatch warns the user of potential AFib activity, prompting them to take an ECG using their watch for a more accurate measurement.
“With the existing blood pressure and heart rate monitoring, this new feature provides users with even deeper insights into their cardiovascular health,” said the company.
AFib is a type of arrhythmia, widely considered a warning sign for major cardiovascular issues including an increased risk of stroke, heart failure and other complications.
Moreover, many cases of AFib are asymptomatic or even silent, leaving people unaware of their risk.
The company said that the irregular heart rhythm notification feature is now available as part of the newly-launched Galaxy Watch7 Ultra, Galaxy Watch7 as well as on Galaxy Watch6, Watch5 and Watch4 series.
A recent study said that work-related stress, particularly high job strain and effort-reward imbalance, may significantly increase the risk of developing AFib. The study, published in the ‘Journal of the American Heart Association’, included nearly 6,000 white-collar workers in Canada.
It found that those experiencing both high job strain and effort-reward imbalance faced 97 per cent increased risk of AFib compared to those not exposed to these stressors.
Previous studies have linked work-related stress with coronary heart disease, but this is the first to examine its impact on AFib, said senior author Xavier Trudel, from Laval University in Quebec, Canada.
–IANS
na/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.